BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1173 related articles for article (PubMed ID: 15180713)

  • 1. Gastroesophageal reflux disease poorly responsive to single-dose proton pump inhibitors in patients without Barrett's esophagus: acid reflux, bile reflux, or both?
    Tack J; Koek G; Demedts I; Sifrim D; Janssens J
    Am J Gastroenterol; 2004 Jun; 99(6):981-8. PubMed ID: 15180713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acid and bile reflux in erosive reflux disease, non-erosive reflux disease and Barrett's esophagus.
    Hak NG; Mostafa M; Salah T; El-Hemaly M; Haleem M; Abd El-Raouf A; Hamdy E
    Hepatogastroenterology; 2008; 55(82-83):442-7. PubMed ID: 18613384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complete elimination of reflux symptoms does not guarantee normalization of intraesophageal and intragastric pH in patients with gastroesophageal reflux disease (GERD).
    Milkes D; Gerson LB; Triadafilopoulos G
    Am J Gastroenterol; 2004 Jun; 99(6):991-6. PubMed ID: 15180715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevalence of a pathological DGER (duodeno-gastric-oesophageal reflux) in patients with clinical symptoms of reflux disease].
    Kunsch S; Linhart T; Fensterer H; Adler G; Gress TM; Ellenrieder V
    Z Gastroenterol; 2008 May; 46(5):409-14. PubMed ID: 18428099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Belching: dyspepsia or gastroesophageal reflux disease?
    Lin M; Triadafilopoulos G
    Am J Gastroenterol; 2003 Oct; 98(10):2139-45. PubMed ID: 14572558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of pantoprazole on duodeno-gastro-esophageal reflux (DGER).
    Kunsch S; Neesse A; Linhart T; Steinkamp M; Fensterer H; Adler G; Gress TM; Ellenrieder V
    Z Gastroenterol; 2009 Mar; 47(3):277-82. PubMed ID: 19280541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of duodeno-gastro-esophageal reflux in the medical outpatient practice.
    Vaezi MF; Richter JE
    Hepatogastroenterology; 1999; 46(25):40-7. PubMed ID: 10228763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Is duodeno-gastro-esophageal reflux just a bystander of acid reflux?].
    Fein M; Fuchs KH; Freys SM; Maroske J; Tigges H; Thiede A
    Zentralbl Chir; 2002 Dec; 127(12):1068-72. PubMed ID: 12529822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duodenogastroesophageal reflux: results of medical treatment and antireflux surgery.
    Elhak NG; Mostafa M; Salah T; Haleem M
    Hepatogastroenterology; 2008; 55(81):120-6. PubMed ID: 18507090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the degree of duodenogastroesophageal reflux and acid reflux between patients who failed to respond and those who were successfully treated with a proton pump inhibitor once daily.
    Gasiorowska A; Navarro-Rodriguez T; Wendel C; Krupinski E; Perry ZH; Koenig K; Moty B; Powers J; Fass R
    Am J Gastroenterol; 2009 Aug; 104(8):2005-13. PubMed ID: 19491829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biliary reflux and non-acid reflux are two distinct phenomena: a comparison between 24-hour multichannel intraesophageal impedance and bilirubin monitoring.
    Pace F; Sangaletti O; Pallotta S; Molteni P; Porro GB
    Scand J Gastroenterol; 2007 Sep; 42(9):1031-9. PubMed ID: 17710667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors.
    Gerson LB; Boparai V; Ullah N; Triadafilopoulos G
    Aliment Pharmacol Ther; 2004 Sep; 20(6):637-43. PubMed ID: 15352912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bile and acid reflux in long and short segment Barrett's esophagus, and in reflux disease.
    Pfaffenbach B; Hullerum J; Orth KH; Langer M; Stabenow-Lohbauer U; Lux G
    Z Gastroenterol; 2000 Jul; 38(7):565-70. PubMed ID: 10965553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Step-down from multiple- to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs.
    Inadomi JM; McIntyre L; Bernard L; Fendrick AM
    Am J Gastroenterol; 2003 Sep; 98(9):1940-4. PubMed ID: 14499769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stratification and symptom characteristics of non-erosive reflux disease based on acid and duodenogastroesophageal reflux.
    Xiong LS; Chen MH; Lin JK; Hu PJ
    J Gastroenterol Hepatol; 2008 Feb; 23(2):290-5. PubMed ID: 17924953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased acid and bile reflux in Barrett's esophagus compared to reflux esophagitis, and effect of proton pump inhibitor therapy.
    Menges M; Müller M; Zeitz M
    Am J Gastroenterol; 2001 Feb; 96(2):331-7. PubMed ID: 11232672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
    Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
    Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duodenogastro-esophageal reflux in children with refractory gastro-esophageal reflux disease.
    Hoffman I; Tertychnyy A; Ectors N; De Greef T; Haesendonck N; Tack J
    J Pediatr; 2007 Sep; 151(3):307-11. PubMed ID: 17719945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of acid and duodenal gastroesophageal reflux in symptomatic GERD.
    Koek GH; Tack J; Sifrim D; Lerut T; Janssens J
    Am J Gastroenterol; 2001 Jul; 96(7):2033-40. PubMed ID: 11467629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics and clinical relevance of proximal esophageal pH monitoring.
    Cool M; Poelmans J; Feenstra L; Tack J
    Am J Gastroenterol; 2004 Dec; 99(12):2317-23. PubMed ID: 15571576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 59.